Emergent Biosolutions Inc Earnings
The next earnings date for Emergent Biosolutions Inc is November 4, 2026.
They are scheduled to announce earnings after the market closes that day.
Analyst Estimates of Emergent Biosolutions Inc Earnings
| 11/04/2026 | $-0.45 |
What is an Earnings Date
An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.
Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.
Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.
Emergent Biosolutions Inc Earnings: Historical
| 08/05/2026 | After Market | $0.60 | 445.45% |
| 04/30/2026 | After Market | $0.21 | 184.00% |
| 02/26/2026 | --- | $-0.43 | -201.18% |
| 10/29/2025 | After Market | $1.06 | 983.33% |
| 08/06/2025 | After Market | $0.16 | 132.65% |
| 05/07/2025 | After Market | $0.71 | 61.36% |
| 03/04/2025 | Before Market | $-0.58 | -16.50% |
| 11/06/2024 | After Market | $1.37 | 878.57% |
| 08/06/2024 | After Market | $-2.32 | -139.18% |
| 05/01/2024 | After Market | $0.59 | 171.08% |
More About Emergent Biosolutions Inc
Emergent BioSolutions Inc., a life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States, Canada, and internationally. It operates through Commercial Products, MCM Products, and All Other Revenues segments. The company offers ACAM2000, a smallpox and mpox vaccine; Anthrax Immune Globulin Intravenous (ANTHRASIL), a polyclonal antibody therapeutic for the treatment of inhalational anthrax; Botulism Antitoxin Heptavalent (BAT), an equine plasma antitoxin for the treatment of symptomatic botulism; BioThrax, an anthrax vaccine; CYFENDUS, a vaccine for post-exposure prophylaxis of disease following suspected or confirmed exposure to Bacillus anthracis; Ebanga, a monoclonal antibody for the treatment of infection caused by Orthoebolavirus zairense; Raxibacumab injection, a monoclonal antibody therapeutic for the treatment and prophylaxis of inhalational anthrax due to Bacillus anthracis; TEMBEXA, an oral antiviral for the treatment of smallpox disease caused by variola virus in adult and pediatric patients; and CNJ-016, a polyclonal antibody therapeutic to address complications from smallpox vaccination. It also provides NARCAN and KLOXXADO nasal sprays for the emergency treatment of known or suspected opioid overdose. In addition, the company offers contract development and manufacturing services comprising drug substance and product manufacturing, and packaging, as well as technology transfer, process, analytical development, and suite reservation services. Emergent BioSolutions Inc. was incorporated in 1998 and is headquartered in Gaithersburg, Maryland.
“Emergent Biosolutions Inc Earnings” Can Refer to the Emergent Biosolutions Inc Earnings Date
Some people say “Emergent Biosolutions Inc earnings” as a shortform way to refer to the earnings date.
For example, someone might say, “I plan to hold my Emergent Biosolutions Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.
Owning Emergent Biosolutions Inc Stock on the Earnings Date
If you own Emergent Biosolutions Inc stock (EBS) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.
A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Emergent Biosolutions Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.
There is often a big audience of investors involved with trading Emergent Biosolutions Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.
These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.
Learning More Emergent Biosolutions Inc Earnings
You can contact us any time if you would like to ask questions about Emergent Biosolutions Inc earnings or anything else related to the stock market.